Bone Biologics Corp
BBLG- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001419554
No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $35.7K in total; no superinvestor holds it.
Other share classesBBLGW
13F holders, Q2 2023
Institutional positions in Bone Biologics Corp as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- −1 vs. Q1 2023
- Shares held
- 404.8K
- −2.10M (−83.8%) vs. Q1 2023
- Total value
- $576.4K
- −$70.9K (−11.0%) vs. Q1 2023
- New holders
- 2
- 0 more added
- Sold out
- 3
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBLG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $35.7K |
| Q1 2026 | 3 | $4.85K |
| Q4 2025 | 7 | $74.1K |
| Q3 2025 | 7 | $36.7K |
| Q2 2025 | 4 | $1.83K |
| Q1 2025 | 4 | $20.8K |
| Q4 2024 | 7 | $55.8K |
| Q3 2024 | 7 | $183.4K |
| Q2 2024 | 5 | $69.7K |
| Q1 2024 | 4 | $89.1K |
| Q4 2023 | 2 | $5.56K |
| Q3 2023 | 8 | $235.1K |
| Q2 2023 | 7 | $576.4K |
| Q1 2023 | 8 | $647.2K |
| Q4 2022 | 12 | $469.7K |
| Q3 2022 | 3 | $43.0K |
| Q2 2022 | 3 | $67.0K |
| Q1 2022 | 4 | $160.0K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Bone Biologics Corp; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Walleye Capital LLC | 295,000 | $418.9K | 0.01% | −511,159−63.4% | Reduced |
| Kepos Capital LP | 50,000 | $72.0K | 0.01% | +50,000 | New |
| Warberg Asset Management LLC | 27,000 | $38.3K | 0.01% | −3,000−10.0% | Reduced |
| Virtu Financial LLC | 15,932 | $23.0K | 0.00% | +15,932 | New |
| Sabby Management, LLC | 10,817 | $15.5K | 0.06% | −1,489,183−99.3% | Reduced |
| Tower Research Capital LLC (TRC) | 6,041 | $8.64K | 0.00% | −2,270−27.3% | Reduced |
| Wells Fargo & Company | 2 | $3 | 0.00% | −50−96.2% | Reduced |
| McMahon Financial Advisors, LLC | 0 | $0 | 0.00% | −96,774−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −43,653−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −17,824−100.0% | Sold out |